https://www.questdiagnostics.com/healthcare-professionals/clinical-education-center/publications/2020/nuclear-nr4a2--nurr1--immunostaining-is-a-novel-marker-
Nuclear NR4A2 (Nurr1) Immunostaining is a Novel Marker for Acinic Cell Carcinoma of the Salivary Glands Lacking the Classic NR4A3 (NOR-1) Upregulation.
nuclearimmunostainingnovelmarker